Kala Bio Inc
(KALA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KALA | AZN | AMGN | GILD | BMY |
| Company | Kala Bio Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.4408 | 191.80 | 380.70 | 151.85 | 61.37 |
| High | 0.4634 | 192.76 | 384.62 | 153.00 | 61.63 |
| Low | 0.4000 | 187.06 | 372.34 | 150.18 | 60.36 |
| Latest | 0.4150 | 188.01 | 375.82 | 151.68 | 60.77 |
| Change | -0.0250 | -5.02 | -8.50 | -0.82 | -1.22 |
| % Change | -5.68% | -2.60% | -2.21% | -0.54% | -1.97% |
| Volume | 747,900 | 3,030,800 | 2,844,000 | 7,431,200 | 14,013,500 |
| 20-Day Average Volume | 1,010,655 | 4,836,453 | 3,122,645 | 8,207,255 | 13,707,115 |
| Previous Close | 0.4400 | 193.03 | 384.32 | 152.50 | 61.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5538 | 187.06 | 345.56 | 136.04 | 56.24 |
| 20-Day Raw Stochastic | 10.58% | 62.49% | 85.77% | 95.67% | 84.95% |
| 20-Day Relative Strength | 34.47 | 52.88 | 66.21 | 75.35 | 68.24 |
| Weighted Alpha | -62.77 | +31.91 | +37.11 | +55.04 | +24.45 |
| Today's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 80% Sell | 100% Buy | 96% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -21.33% since 02/02/26 | -0.21% since 02/02/26 | +9.03% since 02/02/26 | +6.15% since 02/02/26 | +8.73% since 02/02/26 |
| Low | 0.3801 on 02/05/26 | 183.63 on 02/03/26 | 338.59 on 02/03/26 | 142.03 on 02/03/26 | 55.49 on 02/03/26 |
| High | 0.5500 on 02/03/26 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | -34.28% since 01/09/26 | -0.68% since 01/09/26 | +15.25% since 01/09/26 | +25.25% since 01/09/26 | +8.79% since 01/09/26 |
| Low | 0.3801 on 02/05/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 0.7100 on 01/16/26 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | -41.87% since 11/07/25 | +11.14% since 11/07/25 | +17.37% since 11/07/25 | +27.63% since 11/07/25 | +30.16% since 11/07/25 |
| Low | 0.3801 on 02/05/26 | 171.69 on 11/10/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 1.9100 on 12/01/25 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | -94.38% since 08/08/25 | +27.81% since 08/08/25 | +30.39% since 08/08/25 | +27.02% since 08/08/25 | +32.25% since 08/08/25 |
| Low | 0.3801 on 02/05/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 20.6000 on 09/17/25 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,325 | 299,371,776 | 206,949,024 | 189,203,696 | 126,196,336 |
| Shares Outstanding, K | 9,830 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -38,510,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -7,560,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | -2.43 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.07 on 11/19/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/30/26 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.48 | 16.83 | 18.24 | 9.68 |